AAAAAA
Results:
1-21
|
Results: 21
Authors:
MOTHERBY H
ROSS B
KUBE M
GERMING U
HEYLL A
AUL C
BRAUNSTEIN S
GABBERT HE
BOCKING A
Citation: H. Motherby et al., PLEURAL CARCINOSIS CONFIRMED BY ADJUVANT CYTOLOGICAL METHODS - A CASE-REPORT, Diagnostic cytopathology, 19(5), 1998, pp. 370-374
Authors:
MECKENSTOCK G
AUL C
HILDEBRANDT B
HEYLL A
GERMING U
WEHMEIER A
GIAGOUNIDIS A
SUEDHOFF T
BURK M
SOEHNGEN D
SCHNEIDER W
Citation: G. Meckenstock et al., DYSHEMATOPOIESIS IN DE-NOVO ACUTE MYELOID-LEUKEMIA - CELL BIOLOGICAL FEATURES AND PROGNOSTIC-SIGNIFICANCE, Leukemia & lymphoma, 29(5-6), 1998, pp. 523-531
Authors:
ZUCKER TP
FLESCHE CW
GERMING U
SCHROTER S
WILLERS R
WOLF HH
HEYLL A
Citation: Tp. Zucker et al., PATIENT-CONTROLLED VERSUS STAFF-CONTROLLED ANALGESIA WITH PETHIDINE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Pain, 75(2-3), 1998, pp. 305-312
Authors:
GERMING U
GATTERMANN N
MINNING H
HEYLL A
AUL C
Citation: U. Germing et al., PROBLEMS IN THE CLASSIFICATION OF CMML - DYSPLASTIC VERSUS PROLIFERATIVE TYPE, Leukemia research, 22(10), 1998, pp. 871-878
Authors:
AUL C
GERMING U
GATTERMANN N
MINNING H
Citation: C. Aul et al., INCREASING INCIDENCE OF MYELODYSPLASTIC SYNDROMES - REAL OR FICTITIOUS, Leukemia research, 22(1), 1998, pp. 93-100
Authors:
KOBBE G
HEYLL A
ZODLER T
SOHNGEN D
AUL C
THIELE KP
GERMING U
SCHNEIDER W
Citation: G. Kobbe et al., ACUTE ACALCULOUS CHOLECYSTITIS COMPLICATING ORAL RECONTAMINATION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Oncology Reports, 4(4), 1997, pp. 823-824
Authors:
GERMING U
GIAGOUNIDIS A
SCHNEIDER W
Citation: U. Germing et al., IMPROVED PROPHYLAXIS AGAINST OVERWHELMING POSTSPLENECTOMY INFECTIONS, European journal of haematology, 59(5), 1997, pp. 329-330
Authors:
SOHNGEN D
BAUSER U
BOOGEN C
AUL C
FRIELING T
GERMING U
SCHNEIDER P
KOBBE G
HEYLL A
Citation: D. Sohngen et al., DOUBLE TREATMENT OF SEVERE HEPATIC VENOOCCLUSIVE DISEASE AFTER ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION WITH RECOMBINANTTISSUE-PLASMINOGEN ACTIVATOR, Thrombosis and haemostasis, 78(4), 1997, pp. 1299-1300
Authors:
AUL C
GATTERMANN N
GERMING U
SUDHOFF T
HOLLMIG KA
HEYLL A
Citation: C. Aul et al., FATAL HYPERLEUKOCYTIC SYNDROME IN A PATIENT WITH CHRONIC MYELOMONOCYTIC LEUKEMIA, Leukemia research, 21(3), 1997, pp. 249-253
Authors:
HAASE D
SCHANZ J
WULICH J
SCHOCH C
FREUND M
HAFERLACH T
WORMANN B
STAIB P
LENTINI G
BARTELS H
GEISSLER RG
GERMING U
DORGES U
FONATSCH C
HIDDEMANN W
Citation: D. Haase et al., PROGNOSTIC RELEVANCE OF CYTOGENETIC SUBGROUPS IN 357 PATIENTS WITH MYELODYSPLASTIC SYNDROMES, Blood, 90(10), 1997, pp. 2232-2232
Authors:
AUL C
GERMING U
GATTERMANN N
SOHNGEN D
HEYLL A
Citation: C. Aul et al., PROGNOSTIC-SIGNIFICANCE OF SERUM THYMIDIN E KINASE IN THE MYELODYSPLASTIC SYNDROME, Deutsche Medizinische Wochenschrift, 121(37), 1996, pp. 1113-1118
Authors:
GERMING U
SOHNGEN D
HEYLL A
KOBBE G
AUL C
SCHNEIDER W
Citation: U. Germing et al., SEVERE MUSCULOSKELETAL PAIN AFTER CYCLOSPORINE-A TREATMENT IN A PATIENT UNDERGOING ALLOGENEIC BMT, Oncology Reports, 3(4), 1996, pp. 775-776
Authors:
ZAHNER J
FISCHER H
BORCHARD F
GERMING U
SCHNEIDER W
Citation: J. Zahner et al., SPLENOMEGALY AND PORTAL-HYPERTENSION OF U NUSUAL ORIGIN IN A 62-YEAR-OLD MALE-PATIENT, Der Internist, 37(8), 1996, pp. 844-847
Authors:
ZUCKER TP
FLESCHE CW
GERMING U
SCHROTER S
WOLF HH
HEYLL A
Citation: Tp. Zucker et al., PATIENT-CONTROLLED ANALGESIA REDUCES PETHIDINE REQUIREMENT AND IMPROVES PAIN RELIEF AFTER ALLOGENIC BONE-MARROW TRANSPLANTATION, British Journal of Anaesthesia, 76, 1996, pp. 409-409
Authors:
GERMING U
GATTERMANN N
AUL C
Citation: U. Germing et al., RETROSPECTIVE ANALYSIS OF 134 PATIENTS WITH CMML - A HETEROGENOUS ENTITY, Blood, 88(10), 1996, pp. 2311-2311
EXPRESSION OF CD34 AND P-GLYCOPROTEIN - PROGNOSTIC-SIGNIFICANCE IN PRIMARY MYELODYSPLASTIC SYNDROMES
Authors:
RUNDE V
GERMING U
AUL C
Citation: V. Runde et al., EXPRESSION OF CD34 AND P-GLYCOPROTEIN - PROGNOSTIC-SIGNIFICANCE IN PRIMARY MYELODYSPLASTIC SYNDROMES, International journal of oncology, 7(4), 1995, pp. 901-905
Authors:
AUL C
RUNDE V
GERMING U
GATTERMANN N
JAEGER M
SOHNGEN D
HEYLL A
Citation: C. Aul et al., AGGRESSIVE CHEMOTHERAPY OF ADVANCED MYELODYSPLASTIC SYNDROMES - TREATMENT RESULTS AND PROGNOSTIC FACTORS IN 90 PATIENTS, Experimental hematology, 23(8), 1995, pp. 904-904
Authors:
GERMING U
GATTERMANN N
HEYLL A
JAEGER M
SOEHNGEN D
RUNDE V
SCHNEIDER W
AUL C
Citation: U. Germing et al., ACQUIRED IDIOPATHIC SIDEROBLASTIC ANEMIA (AISA) - PROGNOSTIC-SIGNIFICANCE OF INITIAL BONE-MARROW FINDINGS, Blood, 86(10), 1995, pp. 1332-1332
Authors:
AUL C
GATTERMANN N
GERMING U
RUNDE V
HEYLL A
SCHNEIDER W
Citation: C. Aul et al., RISK ASSESSMENT IN PRIMARY MYELODYSPLASTIC SYNDROMES - VALIDATION OF THE DUSSELDORF SCORE, Leukemia, 8(11), 1994, pp. 1906-1913
Authors:
AUL C
GATTERMANN N
GERMING U
WINKELMAN M
HEYLL A
RUNDE V
SCHNEIDER W
Citation: C. Aul et al., SERUM DEOXYTHYMIDINE KINASE IN MYELODYSPLASTIC SYNDROMES, Cancer, 73(2), 1994, pp. 322-327
Authors:
GERMING U
GATTERMANN N
RUNDE V
HEYLL A
JAEGER M
SCHNEIDER W
AUL C
Citation: U. Germing et al., PROGNOSTIC VALUE OF THE DUSSELDORF-SCORE IN 735 UNTREATED PATIENTS WITH PRIMARY MYELODYSPLASTIC SYNDROMES, Blood, 84(10), 1994, pp. 10000314-10000314
Risultati:
1-21
|